Search - tctmd.com

Displaying 261 - 280 of 308

Sort: Relevancy | Date

Presentation

Stem Cell Treatment for Acute MI

Presenter: D. Clifford

February 16, 2012

News Conference News Cell Therapy 2012

Novel Strategies Advance Cell Therapy for Cardiomyopathy

February 05, 2012

News Conference News Cell Therapy 2012

Expedited Cell Therapy After STEMI Shows Promise

January 29, 2012

Presentation

Periadventitial Multipotent Adult Progenitor Cell Administration in STEMI

Presenter: Marc S. Penn

January 29, 2012

Presentation

Adipose Cells for STEMI: APOLLO and ADVANCE Randomized Trials

Presenter: E. Duckers

January 29, 2012

Presentation Cell Therapy 2012

Selling Cells: The Ethics of Marketing (Unproven) Stem Cell Therapies

Presenter: Timothy Caulfield

January 26, 2012

Presentation Cell Therapy 2012

Correlation of Early Surrogate and Late Clinical Outcomes in Randomized Controlled Studies of Stem Cell Therapy for Acute MI – Implications for Endpoint Selection

Presenter: Stephen G. Ellis

January 26, 2012

Presentation Cell Therapy 2012

Patient Access to Stem Cell Technology: The OKYANOS Heart Institute

Presenter: Matthew Feshbach

January 26, 2012

Presentation Cell Therapy 2012

Mega-Trial Logistics and Considerations: BAMI-STEMI

Presenter: Andreas M. Zeiher

January 26, 2012

Presentation Cell Therapy 2012

Long-term Follow-up of Patients with AMI Treated with Adipose-Derived Stem Cells (APOLLO)

Presenter: Henricus J. Duckers

January 25, 2012

Presentation Cell Therapy 2012

Trial 1: SCIPIO: Autologous Cardiac-Derived Stem Cells for LV Dysfunction

Presenter: Roberto Bolli

January 25, 2012

Presentation Cell Therapy 2012

The CADUCEUS (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction) Trial

Presenter: Raj R. Makkar

January 25, 2012

Presentation Cell Therapy 2012

LATE-TIME: Delayed Delivery of Bone Marrow-Derived Stem Cells Following STEMI

Presenter: Timothy Henry

January 25, 2012

Presentation Cell Therapy 2012

Alster Stem Cell: NOGA-XP Guided Intramyocardial Autologous Cell Therapy Improves LV Function After Large Acute Myocardial Infarct

Presenter: Martin Bergmann

January 25, 2012

Presentation Cell Therapy 2012

Periadventitial MAPC Administration in STEMI

Presenter: Marc S. Penn

January 25, 2012

Presentation Cell Therapy 2012

Rescuing from Smoke-Induced Pathology: Moving from Adipose-Derived Stem Cells to Their Secretome

Presenter: Keith L. March

January 24, 2012

Presentation Cell Therapy 2012

New, Potent, and Safe Source of Human MSCs: From Human Embryonic Stem Cells

Presenter: Hyo-Soo Kim

January 24, 2012

Presentation Cell Therapy 2012

Differential Effects of Host Macrophages on the Survival and Function of Mesenchymal Stem Cells

Presenter: Donald Freytes

January 24, 2012

Presentation Cell Therapy 2012

Complement Cascade and Bioactive Phospholipids: Novel Factors in Stem Cell Mobilization and Tissue Regeneration

Presenter: Wojciech Wojakowski

January 24, 2012

Presentation Cell Therapy 2012

Bioengineering Platforms for Stem Cell Delivery

Presenter: Gordana Vunjak-Novakovic

January 24, 2012

Advertisement

Stem Cell Treatment for Acute MI

Novel Strategies Advance Cell Therapy for Cardiomyopathy

Expedited Cell Therapy After STEMI Shows Promise

Periadventitial Multipotent Adult Progenitor Cell Administration in STEMI

Adipose Cells for STEMI: APOLLO and ADVANCE Randomized Trials

Selling Cells: The Ethics of Marketing (Unproven) Stem Cell Therapies

Correlation of Early Surrogate and Late Clinical Outcomes in Randomized Controlled Studies of Stem Cell Therapy for Acute MI – Implications for Endpoint Selection

Patient Access to Stem Cell Technology: The OKYANOS Heart Institute

Mega-Trial Logistics and Considerations: BAMI-STEMI

Long-term Follow-up of Patients with AMI Treated with Adipose-Derived Stem Cells (APOLLO)

Trial 1: SCIPIO: Autologous Cardiac-Derived Stem Cells for LV Dysfunction

The CADUCEUS (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction) Trial

LATE-TIME: Delayed Delivery of Bone Marrow-Derived Stem Cells Following STEMI

Alster Stem Cell: NOGA-XP Guided Intramyocardial Autologous Cell Therapy Improves LV Function After Large Acute Myocardial Infarct

Periadventitial MAPC Administration in STEMI

Rescuing from Smoke-Induced Pathology: Moving from Adipose-Derived Stem Cells to Their Secretome

New, Potent, and Safe Source of Human MSCs: From Human Embryonic Stem Cells

Differential Effects of Host Macrophages on the Survival and Function of Mesenchymal Stem Cells

Complement Cascade and Bioactive Phospholipids: Novel Factors in Stem Cell Mobilization and Tissue Regeneration

Bioengineering Platforms for Stem Cell Delivery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content